Panacea Biotec Pharma Ltd
Everolimus (0.5mg)
Evergraf 0.5mg Tablet is used for the prevention of organ rejection in transplant patients and in combination with other medicines to treat cancers of breast, pancreas, lungs, and kidney.
Tablet
Evergraf 0.5mg Tablet is used for the prevention of organ rejection in transplant patients. It regulates the body's immune response, so the body can accept the new organ. It is also used in combination with other medicines to treat cancers of breast, pancreas, lungs, and kidney.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Evergraf 0.5mg Tablet may be taken with or without food but it is better to take it at a fixed time.
Evergraf 0.5mg Tablet suppresses the activity of body's immune system and prevents rejection of the transplanted organ.
Evergraf 0.5mg Tablet is given for the treatment of certain cancers and to prevent organ transplant rejection. It may affect male or female fertility; consult your doctor if you are planning to have a child. Inform your doctor straight away if you think you are getting a sore throat or if you have a high temperature. While you are taking Evergraf 0.5mg Tablet do not take any vaccinations without talking to your doctor first. Do not drink grapefruit juice while you are taking this medicine.
Regular blood tests are required to monitor your red blood cell, white blood cell, and platelet counts, as well as your kidney function, liver function, blood glucose levels, and cholesterol levels.
You should avoid consuming grapefruit or grapefruit juice, as this can increase the levels of Evergraf 0.5mg Tablet in your blood to harmful levels. Additionally, you should avoid live vaccinations and any possible contact with individuals who have received live vaccinations.
Evergraf 0.5mg Tablet can cause severe allergic reactions, angioedema, and kidney failure, which can be life-threatening. It is also possible to develop infections or experience breathing problems while taking this medication.
Evergraf 0.5mg Tablet is an anticancer medicine that belongs to the kinase inhibitor class. It works by reducing the blood supply to tumors, slowing down cancer cell growth and spread.
Evergraf 0.5mg Tablet is usually taken once or twice daily with food or on an empty stomach. It should be swallowed whole with water, without crushing or chewing the tablet.
The duration of treatment with Evergraf 0.5mg Tablet is determined by your doctor and may continue until clinical benefit is seen, unacceptable toxicity occurs, or side effects become too severe.
Regular brain scans as advised by your doctor will show the effect of Evergraf 0.5mg Tablet on your brain tumor's size and progression.
Yes, Evergraf 0.5mg Tablet is cytotoxic against human cancer cells in various types of cancer, including breast, stomach, prostate, and kidney (renal cell carcinoma) cancer.